Poolbeg Pharma announces expansion of POLB 001 into oncology

By: TheNewswire.com

January 18, 2023 at 08:10 AM EST

Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO Jeremy Skillington speaks to Proactive's Thomas Warner after announcing that the company has submitted a patent application for the use of POLB 001 in a new oncological indication. Skillington explains the reasons for the strategic expansion and reveals more about his vision for the molecule in the long term.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

More News

D-Wave: Time to Buy the Dip? Or is the Fall Just Starting? ↗

Today 18:55 EST

Via MarketBeat

Hims, Block, and NRG Just Launched Huge Stock Buybacks ↗

Today 17:32 EST

Via MarketBeat

Retail Earnings Roundup: Walmart Scores, Target Slumps in Q3 ↗

Today 16:45 EST

Via MarketBeat

JPMorgan and Goldman Upgrade MP Materials Amid Defense-Driven Demand Outlook ↗

Today 16:15 EST

Via MarketBeat

Why Circle Stock Is Falling—and Why Some Analysts See Big Upside ↗

Today 15:33 EST

Via MarketBeat

Recent Quotes

Symbol	Price	Change (%)
AMZN	226.28	+5.59 (2.53%)
AAPL	275.92	+4.43 (1.63%)
AMD	215.05	+11.27 (5.53%)
BAC	51.93	+0.37 (0.72%)
GOOG	318.47	+18.82 (6.28%)
META	613.05	+18.80 (3.16%)
MSFT	474.00	+1.88 (0.40%)
NVDA	182.55	+3.67 (2.05%)
ORCL	200.28	+1.52 (0.76%)
TSLA	417.78	+26.69 (6.82%)

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.